Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US OptionsDetailed Quotes
MYGN250516P33000
- 0.00
- 0.000.00%
15min DelayClose Apr 30 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest33.00Strike Price0.00Turnover478.22%IV-345.34%PremiumMay 16, 2025Expiry Date25.59Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8480Delta0.0331Gamma0.29Leverage Ratio-0.0520Theta-0.0090Rho-0.24Eff Leverage0.0036Vega
Myriad Genetics Newsroom
Leerink Partners Maintains Myriad Genetics(MYGN.US) With Hold Rating
Myriad Genetics Price Target Cut to $14.00/Share From $18.00 by Goldman Sachs
Myriad Genetics Analyst Ratings
Goldman Sachs Maintains Myriad Genetics(MYGN.US) With Buy Rating, Cuts Target Price to $14
TD Cowen Maintains Myriad Genetics(MYGN.US) With Hold Rating, Cuts Target Price to $11
Myriad Genetics Cut to Neutral From Buy by Guggenheim
Guggenheim Downgrades Myriad Genetics(MYGN.US) to Hold Rating
Scotiabank Maintains Myriad Genetics(MYGN.US) With Buy Rating, Cuts Target Price to $20
Myriad Genetics Analyst Ratings
Scotiabank Maintains Sector Outperform on Myriad Genetics, Lowers Price Target to $20
Myriad Genetics (MYGN) Receives a Buy From Scotiabank
Myriad Genetics Raised to Overweight From Neutral by Piper Sandler
Wells Fargo Maintains Myriad Genetics(MYGN.US) With Buy Rating, Cuts Target Price to $22
Morgan Stanley Maintains Myriad Genetics(MYGN.US) With Hold Rating, Cuts Target Price to $16
Piper Sandler Upgrades Myriad Genetics(MYGN.US) to Buy Rating, Raises Target Price to $12.5
Buy Rating on Myriad Genetics: Strategic Changes and Growth Potential Amid Challenges
Piper Sandler Maintains Myriad Genetics(MYGN.US) With Hold Rating, Cuts Target Price to $11.5
Myriad Genetics Is Maintained at Underperform by B of A Securities
Myriad Genetics Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Quest Diagnostics (DGX) and Myriad Genetics (MYGN)
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now